Understanding what is the mechanism of action of Byfavo?
•
3 min read
Byfavo (remimazolam) was the first new sedative approved for procedural sedation in over two decades, representing a significant innovation in short-acting anesthesia. Understanding **what is the mechanism of action of Byfavo** is key to appreciating its fast-acting effects and predictable recovery profile for patients undergoing short procedures.
